TI Q4 FY26 Concall Summary & Key Takeaways (TI)

TI Q4 FY26 (Mar-2026 Qtr) Earnings call highlights: Key takeaways, performance, financial metrics, outlook and guidance, concerns and management tone.

Tilaknagar Industries Ltd (TI) Q4FY26 Concall Summary - Mar-2026 Qtr

Performance Overview

  • The company reported a landmark year, achieving a total volume of nearly 20 million cases in FY26, significantly boosted by the inclusion of the Imperial Blue (IB) business for four months.
  • Mansion House Brandy solidified its market leadership, crossing the 10 million case volume benchmark in FY26, establishing itself as India's largest PNA Brandy.
  • Quarterly volumes saw a massive increase of 135% year-over-year, reaching over 8 million cases in Q4 FY26, with the newly acquired Imperial Blue business contributing 4.6 million cases.
  • The company has successfully transitioned 75% of the Imperial Blue business operations away from the Transitional Services and Manufacturing Agreement (TSMA) with Pernod Ricard by the end of Q4 FY26, demonstrating strong execution on the integration plan.
  • Tilaknagar Industries continues to dominate the PNA IMFL market in Southern India, holding a market share of nearly 40% in Q4 FY26.

Financial Metrics

Log in to Stocksigma to read the Financial Metrics section of this summary.

Operating Performance / Business Segments

Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.

Key Discussions & Insights

Log in to Stocksigma to read the Key Discussions & Insights section of this summary.

Outlook and Guidance

Log in to Stocksigma to read the Outlook and Guidance section of this summary.

Challenges / Concerns

Log in to Stocksigma to read the Challenges / Concerns section of this summary.

Industry / Competitive Landscape

Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.

Overall Summary

Log in to Stocksigma to read the Overall Summary section of this summary.